Head-To-Head Comparison: InnovAge (INNV) & The Competition

InnovAge (NASDAQ:INNV) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it contrast to its competitors? We will compare InnovAge to similar businesses based on the strength of its valuation, dividends, analyst recommendations, profitability, earnings, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of current recommendations for InnovAge and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	1	2	1	0	2.00
InnovAge Competitors	1877	7751	13384	833	2.55

InnovAge presently has a consensus price target of $10.50, suggesting a potential upside of 10.88%. As a group, “Healthcare Providers & Services” companies have a potential upside of 13.47%. Given InnovAge’s competitors stronger consensus rating and higher probable upside, analysts clearly believe InnovAge has less favorable growth aspects than its competitors.

Valuation & Earnings

This table compares InnovAge and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
InnovAge	$989.71 million	-$2.54 million	157.83
InnovAge Competitors	$21.39 billion	$301.67 million	-1.73

InnovAge’s competitors have higher revenue and earnings than InnovAge. InnovAge is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Insider and Institutional Ownership

12.3% of InnovAge shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 1.1% of InnovAge shares are held by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Risk and Volatility

InnovAge has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500. Comparatively, InnovAge’s competitors have a beta of 0.98, suggesting that their average stock price is 2% less volatile than the S&P 500.

Profitability

This table compares InnovAge and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InnovAge	0.88%	3.63%	1.64%
InnovAge Competitors	-7.86%	-135.41%	-1.59%

Summary

InnovAge competitors beat InnovAge on 9 of the 13 factors compared.

InnovAge Company Profile

InnovAge, Inc. provides integrated healthcare and social services to older adults through the Program of All-Inclusive Care for the Elderly (PACE). The program serves people who qualify for nursing-home-level care but can continue living in their communities with coordinated support. InnovAge’s services include primary and specialty care coordination, nursing, rehabilitation, social services, prescription medications, transportation, in-home assistance and adult day health services. Care is coordinated by interdisciplinary teams and delivered through a combination of community-based centers and support at home.